Sundaram Shanmuga, Punj Jyotsna
Department of Anesthesiology, All India Institute of Medical Sciences, New Delhi, India.
Pain Med. 2020 Jun 1;21(6):1208-1215. doi: 10.1093/pm/pnz370.
The glossopharyngeal nerve lies posterior to the internal carotid artery at the submandibular region. The primary objective of this study was to compare ultrasound-guided glossopharyngeal nerve block (UGPNB) and landmark glossopharyngeal nerve block (GPNB).
MATERIALS & METHODS: Inclusion criteria were patients with unilateral Eagle syndrome and ear pain. Group UGPNB (N = 25) received three UGPNBs at weekly intervals with 1.5 mL of 0.5% ropivacaine and 20 mg of methylprednisolone. Group GPNB (N = 26) received landmark GPNB. Pain intensity was evaluated with the numerical rating scale (NRS) before every block, 30 minutes after every block, and at one, three, and five weeks after the third block. Quality of life, assessed using the Brief Pain Inventory (BPI), and satisfaction scores were noted.
NRS scores before the second and third blocks and a week after were significantly lower in group UGPNB and comparable at weeks 3 and 5. NRS scores 30 minutes after every block were significantly decreased from the preblock values but were comparable between groups. In 68% of patients, a curvilinear probe delineated the internal carotid artery (ICA). Out-of-plane needle trajectory was required in 64% of patients. BPI and satisfaction scores were significantly better in the UGPNB group in the "block" weeks.
UGPNB with 1.5 mL of 0.5% ropivacaine and 20 mg of methylprednisolone injected posterior to the ICA in the submandibular region provides better pain relief for at least a week compared with an extraoral landmark technique when three weekly consecutive blocks are given. In most patients, a curvilinear probe and out-of-plane needle trajectory are most suitable for ultrasound block.
在颌下区域,舌咽神经位于颈内动脉后方。本研究的主要目的是比较超声引导下舌咽神经阻滞(UGPNB)和体表标志法舌咽神经阻滞(GPNB)。
纳入标准为单侧鹰综合征和耳痛患者。UGPNB组(N = 25)每周接受3次UGPNB,注射1.5 mL 0.5%罗哌卡因和20 mg甲泼尼龙。GPNB组(N = 26)接受体表标志法GPNB。在每次阻滞前、每次阻滞后30分钟以及第三次阻滞后1周、3周和5周,使用数字评定量表(NRS)评估疼痛强度。记录使用简明疼痛量表(BPI)评估的生活质量和满意度评分。
UGPNB组在第二次和第三次阻滞前及一周后的NRS评分显著更低,在第3周和第5周时两组相当。每次阻滞后30分钟的NRS评分较阻滞前显著降低,但两组间相当。68%的患者中,曲线探头可清晰显示颈内动脉(ICA)。64%的患者需要采用平面外进针轨迹。在“阻滞”周期间,UGPNB组的BPI和满意度评分显著更好。
当连续3周每周进行一次阻滞时,在颌下区域于ICA后方注射1.5 mL 0.5%罗哌卡因和20 mg甲泼尼龙的UGPNB与口外体表标志技术相比,至少在一周内可提供更好的疼痛缓解。在大多数患者中,曲线探头和平面外进针轨迹最适合超声引导下的阻滞。